載入...
Laquinimod dampens hyperactive cytokine production in Huntington's disease patient myeloid cells
Huntington's disease (HD) is a neurodegenerative condition characterized by pathology in the brain and peripheral tissues. Hyperactivity of the innate immune system, due in part to NFκB pathway dysregulation, is an early and active component of HD. Evidence suggests targeting immune disruption...
Na minha lista:
發表在: | J Neurochem |
---|---|
Main Authors: | , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
John Wiley and Sons Inc.
2016
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4982105/ https://ncbi.nlm.nih.gov/pubmed/26823290 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jnc.13553 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|